132 related articles for article (PubMed ID: 10331967)
1. Trisomy 8 in stage I and stage III ovarian cancer detected by fluorescence in situ hybridization.
Mark HF; Afify AM; Werness BA; Das S; Mark S; Samy M
Exp Mol Pathol; 1999 Apr; 66(1):76-81. PubMed ID: 10331967
[TBL] [Abstract][Full Text] [Related]
2. HER-2/neu oncogene amplification in stage I and stage III ovarian papillary serous carcinoma.
Afify AM; Werness BA; Mark HF
Exp Mol Pathol; 1999 Jun; 66(2):163-9. PubMed ID: 10409445
[TBL] [Abstract][Full Text] [Related]
3. Assessment of chromosome 8 copy number in cervical cancer by fluorescent in situ hybridization.
Mark HF; Feldman D; Samy M; Sun C; Das S; Mark S; Lathrop J
Exp Mol Pathol; 1999 Jun; 66(2):157-62. PubMed ID: 10409444
[TBL] [Abstract][Full Text] [Related]
4. Assessment of chromosomal trisomies in prostate cancer using fluorescent in situ hybridization.
Mark HF; Feldman D; Das S; Samy M; Sun CL; Mark S
Exp Mol Pathol; 1999 Oct; 67(2):109-17. PubMed ID: 10527762
[TBL] [Abstract][Full Text] [Related]
5. [Detection of chromosome 8 anomalies in ovarian carcinoma by fluorescence in situ hybridization].
Dong YL; Li CH; Chen LX; Feng HY; Zhu BS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):59-60. PubMed ID: 12579504
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
[TBL] [Abstract][Full Text] [Related]
7. [Detection of extra chromosomes 12 by fluorescent in situ hybridization (FISH) in ovarian stromal tumors. Study of 12 cases and review of the literature].
Gancberg D; Scourneau M; Verdebout JM; Larsimont D; Verhest A
Ann Pathol; 2001 Oct; 21(5):393-8. PubMed ID: 11852357
[TBL] [Abstract][Full Text] [Related]
8. Analysis of cytogenetic alterations in stage III serous ovarian adenocarcinoma reveals a heterogeneous group regarding survival, surgical outcome, and substage.
Partheen K; Levan K; Osterberg L; Helou K; Horvath G
Genes Chromosomes Cancer; 2004 Aug; 40(4):342-8. PubMed ID: 15188458
[TBL] [Abstract][Full Text] [Related]
9. Interphase fluorescence in situ hybridization studies of ovarian adenocarcinomas using the midisatellite probe.
Kalir T; Eisberg A; Dottino P; Cohen C
Gynecol Oncol; 1999 Feb; 72(2):208-14. PubMed ID: 10021303
[TBL] [Abstract][Full Text] [Related]
10. Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization.
Mendelin J; Grayson M; Wallis T; Visscher DW
Lab Invest; 1999 Apr; 79(4):387-93. PubMed ID: 10211991
[TBL] [Abstract][Full Text] [Related]
11. ERBB2 and chromosome 17 centromere studies of ovarian cancer by fluorescence in situ hybridization.
Young SR; Liu WH; Brock JA; Smith ST
Genes Chromosomes Cancer; 1996 Jun; 16(2):130-7. PubMed ID: 8818660
[TBL] [Abstract][Full Text] [Related]
12. Detection of trisomy 12 on ovarian sex cord stromal tumors by fluorescence in situ hybridization.
Taruscio D; Carcangiu ML; Ward DC
Diagn Mol Pathol; 1993 Jun; 2(2):94-8. PubMed ID: 8269283
[TBL] [Abstract][Full Text] [Related]
13. Numerical chromosomal aberrations in borderline, benign, and malignant epithelial tumors of the ovary: correlation with p53 protein overexpression and Ki-67.
Kohlberger PD; Kieback DG; Mian C; Wiener H; Kainz C; Gitsch G; Breitenecker G
J Soc Gynecol Investig; 1997; 4(5):262-4. PubMed ID: 9360232
[TBL] [Abstract][Full Text] [Related]
14. Interphase fluorescence in situ hybridization for trisomy 12 on archival ovarian sex cord-stromal tumors.
Shashi V; Golden WL; von Kap-Herr C; Andersen WA; Gaffey MJ
Gynecol Oncol; 1994 Dec; 55(3 Pt 1):349-54. PubMed ID: 7835773
[TBL] [Abstract][Full Text] [Related]
15. [Oncogene ZNF217 amplification on chromosome 20 q in ovarian serous cystadenocarcinoma and its clinical implications].
Li J; Zhong M; Song LL; Su GD
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):824-5. PubMed ID: 16793610
[TBL] [Abstract][Full Text] [Related]
16. Early involvement of 6q in surface epithelial ovarian tumors.
Tibiletti MG; Bernasconi B; Furlan D; Riva C; Trubia M; Buraggi G; Franchi M; Bolis P; Mariani A; Frigerio L; Capella C; Taramelli R
Cancer Res; 1996 Oct; 56(19):4493-8. PubMed ID: 8813146
[TBL] [Abstract][Full Text] [Related]
17. Association of 20q13.2 copy number changes with the advanced stage of ovarian cancer-tissue microarray analysis.
Dimova I; Yosifova A; Zaharieva B; Raitcheva S; Doganov N; Toncheva D
Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):81-5. PubMed ID: 15596278
[TBL] [Abstract][Full Text] [Related]
18. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours.
Evans MF; McDicken IW; Herrington CS
J Pathol; 1999 Sep; 189(1):53-9. PubMed ID: 10451488
[TBL] [Abstract][Full Text] [Related]
19. [ZNF217 gene was detected in ovarian serous cystadenocarcinoma by fluorescence in situ hybridization].
Zhong M; Li J; Ding YQ; Song LL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):665-7. PubMed ID: 17160949
[TBL] [Abstract][Full Text] [Related]
20. [Detection of abnormal numbers of chromosome 8 with interphase fluorescence in situ hybridization in hematologic malignancies].
Wang HP; Li GX; Qiao ZH; Wang HW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):395-7. PubMed ID: 15300644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
